Skip to main content

Table 1 Baseline characteristics of recently nonadherent patients who were subsequently initiated on depot and patients who were not

From: Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients

Variable Depot Initiators (n = 39) Non-Depot Initiators (n = 275) Comparison P-value
Age at baseline, mean (SD) 34.7 (10.8) 40.8 (11.0) .001
Gender, Male, n (%) 25 (64.1%) 157 (57.1%) .489
Race, n (%)    .339
   White 17 (43.6%) 153 (55.8%)  
   Black 19 (48.7%) 102 (37.2%)  
   Other 3 (7.7%) 19 (6.9%)  
Marital status, married, n (%) 13 (33.3%) 122 (44.9%) .226
High school education or higher, n (%) 21 (53.8%) 182 (66.7%) .150
Age at illness onset, mean (SD), years 17.7 (6.5) 19.2 (9.5) .373
Health Insurance, n (%)    .771
   Medicaid 29 (74.4%) 180 (65.5%)  
   Medicare 11 (28.2%) 95 (34.5%)  
   Medicaid and Medicare 8 (20.5%) 54 (19.6%)  
PANSS total score at enrollment, mean (SD) 70.3 (20.6) 68.8 (18.2) .711
PANSS positive score at enrollment, mean (SD) 16.9 (6.6) 16.0 (6.1) .516
PANSS negative score at enrollment, mean (SD) 18.8 (6.2) 17.5 (5.5) .291
PANSS general psychopathology score at enrollment, mean (SD) 35.4 (11.4) 35.3 (10.0) .970
Mental retardation/borderline IQ, n (%) 2 (5.1%) 5 (1.8%) .211
Supervised housing, n (%) 4 (10.3%) 19 (6.9%) .506